布苯丙胺:修订间差异

来自Hyacinth
跳转到导航 跳转到搜索
删除的内容 添加的内容
草awa留言 | 贡献
Created page with "布苯丙胺('''Dimethoxybromoamphetamine''','''brolamfetamine''',<ref name="Organization2000">{{cite book|author=World Health Organization|title=International Nonproprietary Names (INN) for Pharmaceutical Substances|url=https://books.google.com/books?id=HcogPwAACAAJ|year=2000|publisher=World Health Organization|isbn=978-0-11-986227-0}}</ref>'''DOB''','''bromo-DMA''')是一种苯丙胺致幻剂,它最早由亚历山大·舒尔金在1967年合..."
 
草awa留言 | 贡献
无编辑摘要
 
(未显示同一用户的1个中间版本)
第1行: 第1行:
{{Drugbox
布苯丙胺('''Dimethoxybromoamphetamine''','''brolamfetamine''',<ref name="Organization2000">{{cite book|author=World Health Organization|title=International Nonproprietary Names (INN) for Pharmaceutical Substances|url=https://books.google.com/books?id=HcogPwAACAAJ|year=2000|publisher=World Health Organization|isbn=978-0-11-986227-0}}</ref>'''DOB''','''bromo-DMA'''是一种[[苯丙胺]]类[[致幻剂]],它最早由[[亚历山大·舒尔金]]在1967年合成。<ref name="dob-pihkal">[http://www.erowid.org/library/books_online/pihkal/pihkal062.shtml Erowid Online Books: "PiHKAL" - #62 DOB]</ref><ref name=dob1973>{{cite journal |doi=10.1159/000136181 |pmid=5570923|title=4-Bromo-2,5-Dimethoxyphenylisopropylamine, a New Centrally Active Amphetamine Analog|journal=Pharmacology|volume=5|issue=2|pages=103–107|year=1971|last1=Shulgin|first1=A.T.|last2=Sargent|first2=T.|last3=Naranjo|first3=C.|s2cid=46844380}}</ref>
| image = Structure_of_dimethoxybromoamphetamine.svg
<!-- 化学数据 -->
| C=11 | H=16 | Br=1 | N=1 | O=2

|IUPAC_name = 1-(4-溴-2,5-二甲氧基苯基)丙-2-胺
|PubChem = 62065
| CAS_number = 64638-07-9
| CAS_supplemental = (消旋体)
| CAS_number2 = 43061-15-0
| CAS_supplemental2 = (右旋体)
| CAS_number3 = 43061-16-1
| CAS_supplemental3 = (左旋体)
}}

{{DrugNamebox
|alias={{seplist
| 4-溴-2,5-二甲氧基苯丙胺
| 2,5-二甲氧基-4-溴苯丙胺
| Dimethoxybromoamphetamine
| Brolamfetamine<ref name="Organization2000">{{cite book|author=World Health Organization|title=International Nonproprietary Names (INN) for Pharmaceutical Substances|url=https://books.google.com/books?id=HcogPwAACAAJ|year=2000|publisher=World Health Organization|isbn=978-0-11-986227-0}}</ref>
}}
|abbr={{seplist
|DOB
|bromo-DMA
}}
}}


'''布苯丙胺'''是一种[[苯丙胺]]类[[致幻剂]],它最早由[[亚历山大·舒尔金]]在1967年合成。<ref name="dob-pihkal">[http://www.erowid.org/library/books_online/pihkal/pihkal062.shtml Erowid Online Books: "PiHKAL" - #62 DOB]</ref><ref name=dob1973>{{cite journal |doi=10.1159/000136181 |pmid=5570923|title=4-Bromo-2,5-Dimethoxyphenylisopropylamine, a New Centrally Active Amphetamine Analog|journal=Pharmacology|volume=5|issue=2|pages=103–107|year=1971|last1=Shulgin|first1=A.T.|last2=Sargent|first2=T.|last3=Naranjo|first3=C.|s2cid=46844380}}</ref>


== 药理学 ==
== 药理学 ==

2024年10月30日 (三) 11:27的最新版本

布苯丙胺
化学数据
化学式C11H16BrNO2
摩尔质量274.16 g·mol−1
识别信息
IUPAC名称1-(4-溴-2,5-二甲氧基苯基)丙-2-胺
CAS号
PubChem CID
布苯丙胺
别名
  • 4-溴-2,5-二甲氧基苯丙胺

  • 2,5-二甲氧基-4-溴苯丙胺

  • Dimethoxybromoamphetamine

  • Brolamfetamine[1]
缩写
  • DOB

  • bromo-DMA


布苯丙胺是一种苯丙胺致幻剂,它最早由亚历山大·舒尔金在1967年合成。[2][3]

药理学

布苯丙胺是5-HT2A5-HT2B5-HT2C受体激动剂或部分激动剂。[4]它的致幻效果是由于其对5-HT2A受体的激动剂特性介导的。布苯丙胺还是人类TAAR1受体激动剂。[5]

布苯丙胺在剂量过大时可能会引起弥漫性动脉痉挛。[6]

法律地位

中国大陆

布苯丙胺在中国大陆于2013年被列入精神药品品种目录第一类。

引用文献

  1. World Health Organization (2000). International Nonproprietary Names (INN) for Pharmaceutical Substances. World Health Organization. ISBN 978-0-11-986227-0.
  2. Erowid Online Books: "PiHKAL" - #62 DOB
  3. Shulgin, A.T.; Sargent, T.; Naranjo, C. (1971). "4-Bromo-2,5-Dimethoxyphenylisopropylamine, a New Centrally Active Amphetamine Analog". Pharmacology. 5 (2): 103–107. doi:10.1159/000136181. PMID 5570923. S2CID 46844380.
  4. Ray, T. S. (2010). "Psychedelics and the Human Receptorome". PLOS ONE. 5 (2): e9019. Bibcode:2010PLoSO...5.9019R. doi:10.1371/journal.pone.0009019. PMC 2814854. PMID 20126400.
  5. Lewin, A. H.; Miller, G. M.; Gilmour, B. (2011). "Articleid 50034244". Binding Database. 19 (23): 7044–7048. doi:10.1016/j.bmc.2011.10.007. PMC 3236098. PMID 22037049. Retrieved 29 April 2014.
  6. Bowen, J. Scott; Davis, Gary B.; Kearney, Thomas E. (1983-03-18). "Diffuse Vascular Spasm Associated With 4-Bromo-2,5-Dimethoxyamphetamine Ingestion". JAMA: The Journal of the American Medical Association (in English). 249 (11): 1477–1479. doi:10.1001/jama.1983.03330350053028. ISSN 0098-7484. PMID 6827726.